February 2021 FDA Recall Pantoprazole Sodium by Sun Pharmaceutical Industries Inc
D-0251-2021 - Failed Impurity/Degradation Specifications
This Class III drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on February 5, 2021 for the product Pantoprazole Sodium. The FDA reported the reason for recall as failed impurity/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0251-2021
Failed Impurity/Degradation Specifications
02-05-2021
02-17-2021
20,475 vials
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
SUN PHARMACEUTICAL INDUSTRIES INC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
11-03-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 62756-129-40
Batch or Lot Expiration Information
Lot# JKU3595A, JKU3596A, JKU3597A, and JKU3629A; Exp 02/2021